JACKSONVILLE, Fla.--(BUSINESS WIRE)--NovaBone Products, a leading biologics bone graft device company, announced that the US Patent and Trademark Office (USPTO) has issued notice of allowance for US patent application 20140017281 for its “novel ionically cross-linked materials and methods for production.”
Help employers find you! Check out all the jobs and post your resume.